Gloucester, MA, United States of America

Stephen J Haggarty

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 5.8

ph-index = 7

Forward Citations = 185(Granted Patents)


Location History:

  • Somerville, MA (US) (2007 - 2012)
  • Bridgewater, MA (US) (2016)
  • Dorchester, MA (US) (2012 - 2023)
  • Gloucester, MA (US) (2015 - 2023)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor Stephen J Haggarty.

Title: The Innovations of Stephen J Haggarty in Neurodegenerative Disorder Treatments

Introduction:

Stephen J Haggarty is a prolific inventor based in Gloucester, MA, who has made significant contributions to the field of neurodegenerative disorder treatments. With a total of 31 patents to his name, Haggarty has been at the forefront of developing novel compounds and methods for addressing complex neurological conditions.

Latest Patents:

1. Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders: This patent focuses on polyhydroxylated benzophenone compounds that show promise in treating neurodegenerative, neurological, psychiatric, and cognitive diseases linked to HDAC1 deacetylase activity deficiencies.

2. Photoswitchable HDAC inhibitors: Haggarty's invention revolves around photoswitchable inhibitors of histone deacetylases, offering innovative approaches to modulating gene expression for therapeutic purposes.

Career Highlights:

Haggarty has lent his expertise to renowned institutions such as The General Hospital Corporation and the Massachusetts Institute of Technology (MIT). With a keen focus on the intersection of chemistry and neurology, he has spearheaded groundbreaking research projects that have the potential to revolutionize treatment strategies for various disorders.

Collaborations:

Throughout his career, Haggarty has collaborated with esteemed professionals in the field, including Li-Huei Tsai and Edward Holson. These partnerships have led to fruitful exchanges of ideas and the development of cutting-edge solutions for complex neurological challenges.

Conclusion:

In conclusion, Stephen J Haggarty stands out as a trailblazer in the realm of neurodegenerative disorder treatments, leveraging his inventive spirit and scientific acumen to drive meaningful advancements in the healthcare sector. His latest patents underscore his commitment to pushing the boundaries of innovation and offering hope to those affected by debilitating conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…